课题基金 / 基金详情

BRD4液相分离的体内功能及其调控超增强子的机制研究

批准号:
31970616
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
范义辉
依托单位:
学科分类:
基因表达及非编码序列调控
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
范义辉

项目摘要

结项摘要

项目成果

范义辉的其他基金

相似基金

相关文献

中文摘要
细胞内“蛋白液相分离”是新发现的重要生物学现象,被认为是细胞高效管理多种生命活动(如超增强子调控的转录)的基础。最近,体外实验表明,超增强子关键蛋白BRD4通过LCD结构域发生液相分离,但体内功能及分子机制还不清楚。因此,我们建立了BRD4-LCD结构域缺陷小鼠(BRD4dLCD),破坏BRD4的液相分离。发现:70%的杂合型小鼠在出生1-3天内因肺发育不全死亡;从存活杂合型小鼠中分离的CD4+T细胞不能向Th9细胞分化;杂合型MEF细胞中,超增强子靶基因C-MYC等表达显著降低。因此,本课题提出BRD4通过液相分离调控超增强子的功能,从而参与肺发育和哮喘的发生。我们将系统研究BRD4液相分离1)在肺发育和哮喘中的作用,2)调控肺发育和哮喘的关键超增强子,3)调控超增强子的分子机制。本课题将从分子机制上阐明BRD4如何通过液相分离来组织超增强子调控靶基因,进而参与正常发育及疾病的发生。
英文摘要
Liquid-liquid phase separation (LLPS) is a recently observed cellular phenomenon that might be the key to understand how do multiple actors inside a cell get together at the right place and time to perform critical functions. BRD4 is a vital epigenetic reader with a unique C-terminal low complexity domain (LCD) that can drive liquid-liquid phase separation but with unknown physiological roles. Here, we established a mouse model (BRD4dLCD) to specifically destroy the C-terminal LCD but leave the N-terminus intact. BRD4dLCD heterozygotes display pre- and postnatal growth defects, and about 70% BRD4dLCD heterozygotes die within three weeks. BRD4dLCD nullizygous are embryonic lethal. The surviving BRD4dLC heterozygotes appear smaller than wild-type littermates. They also showed anatomical defects especially the shorter and bent nasal bone. Interestingly, BRD4dLCD/+ CD4+ T cells are failed to differentiate to Th9 cells in vitro. Furthermore, the expression of super-enhancer-dependent genes such as C-MYC is significantly reduced in BRD4dLCD/+ MEFs compared to wildtype MEFs. Our preliminary results suggest a critical role of BRD4-LLPS in the control of super-enhancers and the development of lung as well as asthma. Here, we will systematically study: (1) the function of BRD4-LLPS in the development of lung and its regulated super-enhancers; (2) the function of BRD4-LLPS in OVA-induced asthma and its regulated super-enhancers; (3) how does BRD4-LLPS regulate the organization and function of super-enhancers. The proposed study will not only provide new insights in the organization of super-enhancers but also provide novel data regarding the in vivo role of BRD4-LLPS.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.1002/adbi.202300334
发表时间: 2024-01-11
期刊: ADVANCED BIOLOGY
影响因子: 3.7
作者: [Chen,Miaomiao, Guo,Xiaohong, Fan,Yihui]
通讯作者: Fan,Yihui
SPACE: a web server for linking chromatin accessibility with clinical phenotypes and the immune microenvironment in pan-cancer analysis
SPACE:一个网络服务器,用于将染色质可及性与泛癌分析中的临床表型和免疫微环境联系起来
DOI: 10.1038/s41423-020-0416-9
发表时间: 2020
期刊: Cellular and Molecular Immunology
影响因子: 24.1
作者: [Wu Yingcheng, Zhao Jingwei, Zhu Haoliang, Fan Zhiwei, Yuan Xinpei, Chen Shiyin, Mao Renfang, Fan Yihui]
通讯作者: Fan Yihui
DOI: 10.1038/s41389-023-00500-3
发表时间: 2023-11-20
期刊: ONCOGENESIS
影响因子: 6.2
作者: [Shi, Conglin, Chen, Liuting, Pi, Hui, Cui, Henglu, Fan, Chenyang, Tan, Fangzheng, Qu, Xuanhao, Sun, Rong, Zhao, Fengbo, Song, Yihua, Wu, Yuanyuan, Chen, Miaomiao, Ni, Wenkai, Qu, Lishuai, Mao, Renfang, Fan, Yihui]
通讯作者: Fan, Yihui
The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation.
癌细胞中 PD-L1 和 PD-L2 的生成:从核染色质重组到细胞外呈递
DOI: 10.1016/j.apsb.2021.09.010
发表时间: 2022-03
期刊: ACTA PHARMACEUTICA SINICA B
影响因子: 14.5
作者: [Fan, Zhiwei, Wu, Changyue, Chen, Miaomiao, Jiang, Yongying, Wu, Yuanyuan, Mao, Renfang, Fan, Yihui]
通讯作者: Fan, Yihui
Relb组建的Il9超增强子在Th9分化和哮喘中的作用及应用研究
  • 批准号:
    31770935
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    范义辉
  • 依托单位:
国内基金
海外基金